“Johnson & Johnson is using artificial intelligence to slash by half the time it takes to generate new leads for developing drugs, the company’s chief information officer said on Monday.
Discovering new products outright and bringing them to market using AI is not yet possible, but J&J is using the new technology to screen the “potential universe” for promising chemical compounds or biologics, CIO Jim Swanson said at the Reuters Momentum AI event in New York…
J&J is also using AI to streamline preparation of documents for regulators. The traditional process for a clinical trial report can take 700 to 900 hours, the CIO said.
That time has gone from ‘700 hours to about 15 minutes,’ Swanson said.”
From Reuters.
